Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
Immunotherapy targeting glioblastoma initiating cells (GIC) is considered a promising strategy. However, GIC are prone to evade immune response and there is a need for potent adjuvants. IFN-β might enhance the immune response and here we define its net effect on the innate immunogenicity of GIC. The...
Main Authors: | Wolpert, Fabian, Happold, Caroline, Reifenberger, Guido, Florea, Ana-Maria, Deenen, René, Roth, Patrick, Neidert, Marian Christoph, Lamszus, Katrin, Westphal, Manfred, Weller, Michael, Eisele, Günter |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595134/ |
Similar Items
-
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM
by: Stojcheva, Nina, et al.
Published: (2016) -
EGFR Amplification and Glioblastoma Stem-Like Cells
by: Liffers, Katrin, et al.
Published: (2015) -
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
by: Codo, Paula, et al.
Published: (2014) -
Control of glioma cell migration and invasiveness by GDF-15
by: Codó, Paula, et al.
Published: (2016) -
Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
by: Wikman, Harriet, et al.
Published: (2012)